Hamman-Rich syndrome in general medical practice

Author(s):  
Vsevolod Skvortsov ◽  
Zhanna Koltavskova

Hamman-Rich syndrome or idiopathic pulmonary fibrosis is a disease of uncertain origin, accompanied by diffuse damage to the lung tissue, with the possible development of respiratory failure and, as a result, death. Its clinical manifestations are coughing and increasing shortness of breath, and «Velcro» rales can also be heard. The disease is usually found among the elderly. The disease greatly reduces quality of life of patients, so it is important to diagnose it in time and draw up the necessary treatment strategy.

Author(s):  
Baruch Vainshelboim ◽  
Jonathan Myers

Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Baruch Vainshelboim()1 and Jonathan Myers2  1Cardiovascular and Metabolic Disease Research Institute, Mountain View, CA, USA 2Cardiology Division, Veterans Affairs Palo Alto Health Care System / Stanford University, Palo Alto, CA, USA © The Authors   Abstract Idiopathic pulmonary fibrosis (IPF) is a debilitating condition that causes severe symptoms, impaired functional capacity and poor quality of life. Exercise training has been shown to be a safe and effective therapy for improving physical function, dyspnea and quality of life in patients with IPF. However, due to pathophysiological limitations and symptom burden, conducting safe and effective exercise interventions is challenging; optimal program components and training modalities are yet to be established. Resistance training (RT) is a well-established exercise modality for combating effects of aging, disuse and chronic diseases, although there are scarce data available among patients with IPF. The current review briefly summarizes the pathophysiology and clinical manifestations of IPF and describes the numerous health and clinical benefits of RT among older adults and patients with respiratory disease. It then explores the potential RT mechanisms for overcoming exercise limitations in IPF, which may provide a therapeutic opportunity for rehabilitation. Finally, the review suggests practical RT recommendations for pulmonary rehabilitation programs in patients with IPF.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
K. Rajala ◽  
J. T. Lehto ◽  
E. Sutinen ◽  
H. Kautiainen ◽  
M. Myllärniemi ◽  
...  

2018 ◽  
Vol 38 (5) ◽  
pp. 273-278 ◽  
Author(s):  
Mansueto Gomes-Neto ◽  
Cassio Magalhães Silva ◽  
Diego Ezequiel ◽  
Cristiano Sena Conceição ◽  
Micheli Saquetto ◽  
...  

2010 ◽  
Author(s):  
Jeffrey J. Swigris ◽  
Sandra R. Wilson ◽  
Kathy E. Green ◽  
David B. Sprunger ◽  
Kevin K. Brown ◽  
...  

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Dimitrios Kalafatis ◽  
Jing Gao ◽  
Ida Pesonen ◽  
Lisa Carlson ◽  
C. Magnus Sköld ◽  
...  

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a disease with poor prognosis mainly affecting males. Differences in clinical presentation between genders may be important both for the diagnostic work-up and for follow-up. In the present study, we therefore explored potential gender differences at presentation in a Swedish cohort of IPF-patients. Methods We studied patients included in the Swedish IPF- registry over a three-year period from its launch in 2014. A cross-sectional analysis was performed for data concerning demographics, lung function, 6- min walking test (6MWT) and quality of life (QoL) (King’s Brief Interstitial Lung Disease (K-BILD) score). Results Three hundred forty- eight patients (250 (72%) males, 98 (28%) females, median age 72 years in both genders) were included in the registry during the study period. Smoking history (N = 169 (68%) vs. N = 53 (54%), p < 0.05), baseline lung function (Forced vital capacity, % of predicted (FVC%): 68.9% ± 14.4 vs. 73.0% ± 17.7, p < 0.05; Total lung capacity, % of predicted (TLC%): 62.2% ± 11.8 vs. 68.6% ± 11.3%, p < 0.001) were significantly different at presentation between males and females, respectively. Comorbidities such as coronary artery disease (OR: 3.5–95% CI: 1.6–7.6) and other cardiovascular diseases (including atrial fibrillation and heart failure) (OR: 3.8–95% CI: 1.9–7.8) also showed significant differences between the genders. The K- BILD showed poor quality of life, but no difference was found between genders in total score (54 ± 11 vs. 54 ± 10, p = 0.61 in males vs. females, respectively). Conclusions This study shows that female patients with IPF have a more preserved lung function than males at inclusion, while males have a significant burden of cardiovascular comorbidities. However, QoL and results on the 6MWT did not differ between the groups. These gender differences may be of importance both at diagnosis and follow- up of patients with IPF.


2020 ◽  
Vol 26 (5) ◽  
pp. 457-463 ◽  
Author(s):  
Katerina Antoniou ◽  
Apostolos Kamekis ◽  
Emmanouil K. Symvoulakis ◽  
Maria Kokosi ◽  
Jeffrey J. Swigris

Sign in / Sign up

Export Citation Format

Share Document